{"entity":{"type":"insider","cik":"0001814872","url":"/insider/0001814872","json_url":"/insider/0001814872.json","name":"Reddoch James F.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":14,"first":"2021-03-04","last":"2022-09-30","span_basis":"filed_date"},"name_variants":[{"name":"Reddoch James F.","source":"filing","n_filings":14,"first_seen":"2021-03-04","last_seen":"2022-09-30"}],"transactions":[{"id":6497566,"accession":"0001209191-22-051637","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-051637","line_url":"/filing/0001209191-22-051637#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":41.2267,"price_display":"41.23","price_state":"stated","total_value":4122670.0,"total_display":"4,122,670.00","total_whole":"4,122,670","shares_owned_after":820800.0,"shares_owned_after_display":"820,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-28","filed_date":"2022-09-30","scope":"insider"},{"id":6914500,"accession":"0000899243-22-021954","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-021954","line_url":"/filing/0000899243-22-021954#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":41.559,"price_display":"41.56","price_state":"stated","total_value":4155900.0,"total_display":"4,155,900.00","total_whole":"4,155,900","shares_owned_after":920800.0,"shares_owned_after_display":"920,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-08","filed_date":"2022-06-10","scope":"insider"},{"id":6496763,"accession":"0001209191-22-032906","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-032906","line_url":"/filing/0001209191-22-032906#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":41.0801,"price_display":"41.08","price_state":"stated","total_value":3081007.5,"total_display":"3,081,007.50","total_whole":"3,081,008","shares_owned_after":1020800.0,"shares_owned_after_display":"1,020,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-05-31","scope":"insider"},{"id":6630515,"accession":"0001209191-22-031366","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-031366","line_url":"/filing/0001209191-22-031366#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75000.0,"shares_display":"75,000","price_per_share":40.4417,"price_display":"40.44","price_state":"stated","total_value":3033127.5,"total_display":"3,033,127.50","total_whole":"3,033,128","shares_owned_after":1095800.0,"shares_owned_after_display":"1,095,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-23","scope":"insider"},{"id":5293538,"accession":"0001209191-21-048313","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-048313","line_url":"/filing/0001209191-21-048313#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8949.0,"shares_display":"8,949","price_per_share":39.7784,"price_display":"39.78","price_state":"stated","total_value":355976.9016,"total_display":"355,976.90","total_whole":"355,977","shares_owned_after":1170800.0,"shares_owned_after_display":"1,170,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-26","filed_date":"2021-07-27","scope":"insider"},{"id":4102555,"accession":"0001209191-21-048310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-048310","line_url":"/filing/0001209191-21-048310#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8949.0,"shares_display":"8,949","price_per_share":39.7784,"price_display":"39.78","price_state":"stated","total_value":355976.9016,"total_display":"355,976.90","total_whole":"355,977","shares_owned_after":1170800.0,"shares_owned_after_display":"1,170,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-26","filed_date":"2021-07-27","scope":"insider"},{"id":4563442,"accession":"0000899243-21-028334","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-028334","line_url":"/filing/0000899243-21-028334#line-3","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2.0,"shares_display":"2","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":84.0,"total_display":"84.00","total_whole":"84","shares_owned_after":1179749.0,"shares_owned_after_display":"1,179,749","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-14","filed_date":"2021-07-14","scope":"insider"},{"id":4563436,"accession":"0000899243-21-028334","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-028334","line_url":"/filing/0000899243-21-028334#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17832.0,"shares_display":"17,832","price_per_share":42.0077,"price_display":"42.01","price_state":"stated","total_value":749081.3064,"total_display":"749,081.31","total_whole":"749,081","shares_owned_after":1179751.0,"shares_owned_after_display":"1,179,751","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-13","filed_date":"2021-07-14","scope":"insider"},{"id":4563430,"accession":"0000899243-21-028334","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-028334","line_url":"/filing/0000899243-21-028334#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":42.04,"price_display":"42.04","price_state":"stated","total_value":4204.0,"total_display":"4,204.00","total_whole":"4,204","shares_owned_after":1197583.0,"shares_owned_after_display":"1,197,583","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-12","filed_date":"2021-07-14","scope":"insider"},{"id":4308950,"accession":"0000950103-21-010245","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950103-21-010245","line_url":"/filing/0000950103-21-010245#line-3","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40655.0,"shares_display":"40,655","price_per_share":42.046,"price_display":"42.05","price_state":"stated","total_value":1709380.13,"total_display":"1,709,380.13","total_whole":"1,709,380","shares_owned_after":1197683.0,"shares_owned_after_display":"1,197,683","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-08","filed_date":"2021-07-08","scope":"insider"},{"id":4308946,"accession":"0000950103-21-010245","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950103-21-010245","line_url":"/filing/0000950103-21-010245#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2192.0,"shares_display":"2,192","price_per_share":42.0104,"price_display":"42.01","price_state":"stated","total_value":92086.7968,"total_display":"92,086.80","total_whole":"92,087","shares_owned_after":1238338.0,"shares_owned_after_display":"1,238,338","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-07","filed_date":"2021-07-08","scope":"insider"},{"id":4308943,"accession":"0000950103-21-010245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950103-21-010245","line_url":"/filing/0000950103-21-010245#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30270.0,"shares_display":"30,270","price_per_share":42.4037,"price_display":"42.40","price_state":"stated","total_value":1283559.999,"total_display":"1,283,560.00","total_whole":"1,283,560","shares_owned_after":1240530.0,"shares_owned_after_display":"1,240,530","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-06","filed_date":"2021-07-08","scope":"insider"},{"id":4828918,"accession":"0000950103-21-008570","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950103-21-008570","line_url":"/filing/0000950103-21-008570#line-4","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":46.4308,"price_display":"46.43","price_state":"stated","total_value":2321540.0,"total_display":"2,321,540.00","total_whole":"2,321,540","shares_owned_after":1270800.0,"shares_owned_after_display":"1,270,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-08","filed_date":"2021-06-08","scope":"insider"},{"id":4828914,"accession":"0000950103-21-008570","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950103-21-008570","line_url":"/filing/0000950103-21-008570","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":46.58838502,"price_display":"46.59","price_state":"stated","total_value":2329419.251,"total_display":"2,329,419.25","total_whole":"2,329,419","shares_owned_after":1323010.0,"shares_owned_after_display":"1,323,010","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-08","scope":"insider","n_lines":2},{"id":4828902,"accession":"0000950103-21-008570","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950103-21-008570","line_url":"/filing/0000950103-21-008570#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":44.5973,"price_display":"44.60","price_state":"stated","total_value":4459730.0,"total_display":"4,459,730.00","total_whole":"4,459,730","shares_owned_after":1370800.0,"shares_owned_after_display":"1,370,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-06-08","scope":"insider"},{"id":5196699,"accession":"0000950103-21-008457","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950103-21-008457","line_url":"/filing/0000950103-21-008457#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":42.1312,"price_display":"42.13","price_state":"stated","total_value":2106560.0,"total_display":"2,106,560.00","total_whole":"2,106,560","shares_owned_after":1470800.0,"shares_owned_after_display":"1,470,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-04","scope":"insider"},{"id":4711936,"accession":"0000950103-21-005663","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950103-21-005663","line_url":"/filing/0000950103-21-005663#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55714.0,"shares_display":"55,714","price_per_share":42.1006,"price_display":"42.10","price_state":"stated","total_value":2345592.8284,"total_display":"2,345,592.83","total_whole":"2,345,593","shares_owned_after":200000.0,"shares_owned_after_display":"200,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-14","filed_date":"2021-04-16","scope":"insider"},{"id":4269610,"accession":"0000950103-21-005529","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950103-21-005529","line_url":"/filing/0000950103-21-005529#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":359.0,"shares_display":"359","price_per_share":42.32,"price_display":"42.32","price_state":"stated","total_value":15192.88,"total_display":"15,192.88","total_whole":"15,193","shares_owned_after":255714.0,"shares_owned_after_display":"255,714","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-12","filed_date":"2021-04-14","scope":"insider"},{"id":4606858,"accession":"0000950103-21-004522","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950103-21-004522","line_url":"/filing/0000950103-21-004522#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43927.0,"shares_display":"43,927","price_per_share":46.3159,"price_display":"46.32","price_state":"stated","total_value":2034518.5393,"total_display":"2,034,518.54","total_whole":"2,034,519","shares_owned_after":256073.0,"shares_owned_after_display":"256,073","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-22","filed_date":"2021-03-24","scope":"insider"},{"id":4664232,"accession":"0000950103-21-003569","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950103-21-003569","line_url":"/filing/0000950103-21-003569","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":"0001814872","owner_name":"Reddoch James F.","owner_display_name":"Reddoch James F.","owner_url":"/insider/0001814872","role":"Officer (EVP, Research & Investments)","role_mark":"O","role_mark_label":"Officer (EVP, Research & Investments)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Research & Investments","security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":46.92158189,"price_display":"46.92","price_state":"stated","total_value":4692158.189,"total_display":"4,692,158.19","total_whole":"4,692,158","shares_owned_after":303510.0,"shares_owned_after_display":"303,510","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-04","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001802768","name":"Royalty Pharma plc","url":"/issuer/0001802768","role":"Officer (EVP & Chief Scientific Officer)","n_filings":14,"first_seen":"2021-03-04","last_seen":"2022-09-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001814872","retrieved_at":"2026-08-27T13:18:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}